NDAORALCAPSULEPriority Review
Approved
Aug 2023
Lifecycle
Growth
Competitive Pressure
0/100
Clinical Trials
3
Mechanism of Action
GABA A Receptor Positive Modulators
Pharmacologic Class:
Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator
Clinical Trials (3)
A Long-Term Study of Patient-Reported Changes in Postpartum Depression Symptoms in People Starting Zuranolone
Started Dec 2025
200 enrolled
Postpartum Depression
A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy
Started Jun 2025
200 enrolled
Depression, Postpartum
Zuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD)
Started Apr 2023
19 enrolled
Major Depressive Disorder
Loss of Exclusivity
LOE Date
Aug 23, 2037
139 months away
Patent Expiry
Aug 23, 2037
Exclusivity Expiry
Oct 31, 2028